Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

Third Quarter 2022 Earnings Release

Regulatory Announcement Third Quarter 2022 Earnings Release The Third Quarter 2022 Earnings Release has been submitted to the National Storage Mechanism and will shortly be available for inspection at: https://data.fca.org.uk/#/nsm/nationalstoragemechanism To view the full document, please paste the following URL into the address bar of your browser. Third Quarter 2022 Earnings Release dated August 24, 2022 http://www.rns-pdf.londonstockexchange.com/rns/1257X_1-2022-8-24.pdf A copy of the Third Quarter 2022 Earnings Release may also be viewed at www.rbc.com. For further

ALEXANDRIA PANKKIIRILIIKE OYJ: ACQUISITION OF OWN SHARES 24.08.2022

ALEXANDRIA PANKKIIRILIIKE OYJ NOTIFICATION    24.08.2022 at 18:30 EET   ALEXANDRIA PANKKIIRILIIKE OYJ: ACQUISITION OF OWN SHARES 24.08.2022   Date 24.08.2022  Exchange transaction Buy  Share class ALEX  Amount 450  Average price/share 7.4800 EURHighest price/share 7.4800 EURLowest price/share 7.4800 EURTotal price 3,366.00 EUR        The shares held by Alexandria Pankkiiriliike Oyj on 24.08.

FISKARS CORPORATION: ACQUISITION OF OWN SHARES 24.08.2022

Fiskars Corporation   Stock Exchange Release 24.08.2022 at 18:30 EET/EEST   FISKARS CORPORATION: ACQUISITION OF OWN SHARES 24.08.2022   Date 24.08.2022  Exchange transaction Buy  Share class FSKRS  Amount  7 100  Average price/share 17,2472 EURHighest price/share 17,3200 EURLowest price/share 17,1200 EURTotal price 122 455,12 EUR        The shares held by Fiskars Corporation on 24.08.2022:   FSKRS 990,005       On

Resolutions at Pharmacolog AB’s (publ) extraordinary general meeting August 24 2022

The shareholders of Pharmacolog in Uppsala AB (publ) held the Extraordinary General Meeting on August 24, 2022 in Uppsala. (information below in Swedish only)StyrelseStämman beslutade om nyval av Björn Varnestig som styrelseledamot för en mandattid som sträcker sig fram till slutet av nästa årsstämma. Noterades att Olof Johansson har meddelat att han avgår som styrelseledamot i bolaget i samband med den extra bolagsstämman. Styrelsen kommer således bestå av styrelseordförande Erik Hedlund samt styrelseledamöterna Carl-Johan Spak, Ragnar Linder, och Björn Varnestig för tiden intill

Second Quarter and first half year results 2022

Fornebu, 24[th] August 2022, Ocean Yield AS (“Ocean Yield” or the “Company”) announces results for the second quarter and first half year 2022.Highlights · EBITDA for Q2 2022 was USD 45.3 million and EBITDA adjusted for finance lease effects was USD 73.6 million. Net profit for the period Q2 2022 was USD 24.6 million and adjusted net profit for Q2 2022 was USD 23.0 million.  · Acquisition of two newbuilding 5,500 TEU container vessels with 7-year charters. · Acquisition of two newbuilding 36,000 cbm ethylene gas vessels with 15-year charters. · Delivery of two newbuilding

Teleste has signed a frame agreement with a major US cable broadband operator and received first orders for its next generation 10G capable cable network technology

Teleste CorporationPress releaseAugust 24, 2022, at 17:50 EET  TELESTE HAS SIGNED A FRAME AGREEMENT WITH A MAJOR US CABLE BROADBAND OPERATOR AND RECEIVED FIRST ORDERS FOR ITS NEXT GENERATION 10G CAPABLE CABLE NETWORK TECHNOLOGYTeleste has signed a frame agreement with a major USA cable broadband operator for the supply of broadband network technology in the USA, including 1.8 GHz amplifiers and Distributed Access Architecture nodes. First orders have been received, and product deliveries are expected to commence mid-2023.The 1.8 GHz technology will enable end user speeds of

MilDef upgrades its financial growth target

As a consequence of the defense market’s development in combination with MilDef’s positioning and future potential, the company’s board raises the growth target from at least 15% per year to at least 25% per year.The new growth target is based on the company’s historic development, analysis of recently won framework agreements, and future business opportunities on the defense markets where MilDef aims to do business. The current growth target of at least 15% yearly growth is now upgraded to at least 25% yearly growth. The upgraded growth target is effective immediately. Other financial

Unprecedented response to the Koenigsegg CC850

We are happy to announce that the CC850 sold out in record time after last week’s reveal in Monterey, California. The appreciation and love for the CC850 went far beyond our wildest expectations. It quickly became evident that the planned number of 50 cars was too limited, as this meant that not even the most loyal of Koenigsegg owners could all get their desired share of CC850s, while hopeful new owners would also not be able to obtain one. Given this, we asked several long-term clients who were early on signing up for the CC850 for their view on a limited raise in numbers to better

European Patent Office approves instagraft patent

S2Medical AB (publ) has today received the response from the European Patent Office that they intend to grant patent protection for the Company’s instagraft technology within around forty European countries. The instagraft technology is a surgical instrument that can be used for minimally invasive skin transplantation and is intended to move this procedure from specialist units out to the primary healthcare units. This would result in a higher number of patients suffering from chronic ulcers getting access to skin transplantation and thereby being able to heal their wounds. ”The

#22-292 Listing of Derivatives at NGM

Information about various derivatives that will be listed at NGM.For more details, see attached file. For further information concerning this NGM notice please contact NGM Listing department on phone +46 8 566 390 20 or listings@ngm.se. Nordic Growth Market NGM AB About NGMNordic Growth Market NGM AB (NGM) is an authorized stock exchange with operations in Sweden, Norway, Denmark and Finland. The exchange is a wholly-owned subsidiary of Boerse Stuttgart, the leading retail exchange in Germany. NGM offers a complete marketplace for exchange traded products and provides a

TC TECH receives order valued at 6 MSEK from Taiwan-based manufacturer of optical films

TC TECH Sweden AB (publ) announces that the company has received an order covering production system for manufacturing of optical films such as LGP’s, front lights and diffusers for mini-LED displays from the Taiwan-based company Global Lighting Technologies. The total order value is approximately 6.0 MSEK.Global Lighting Technologies is a leading company within development and large-scale production of advanced diffusers. The company has over 1,600 employees, and in addition to Taiwan, business operations are also conducted in Japan, China and the United States.  The order includes a

Outokumpu – Announcement regarding change in holdings

Outokumpu OyjStock exchange releaseAugust 24, 2022 at 4.45 pm EETOutokumpu – Announcement regarding change in holdings Outokumpu Oyj (business identity code: 0215254-2) has on August 24, 2022 received a notification based on Chapter 9, Section 5 of the Finnish Securities Market Act. Société Générale SA’s total holding in the shares and voting rights of Outokumpu has fallen below 5% threshold and was below minimum threshold on August 22, 2022. Their earlier holding in the Outokumpu shares and voting rights was 5.03%. Total direct andindirect holdingsof SociétéGénérale SA

Nordic Nanovector ASA: Invitation to Second Quarter and First Half 2022 Results Presentation Webcast

Oslo, Norway, 24 August 2022 Nordic Nanovector ASA (OSE: NANOV) announces that it will report its results for the second quarter and first half 2022 on Wednesday, 31 August 2022. A presentation by Nordic Nanovector's senior management team will be held in-person and webcast live beginning at 8:30am CEST. Venue: Thon Hotel Vika Atrium, Munkedamsveien 45, 0250 Oslo Meeting Room: Bjørvika The webcast can be accessed from www.nordicnanovector.com in the section: Investors & Media and a recording will also be available on this page after the event. The results report and the

Holding(s) in Company

TR-1: Standard form for notification of major holdings [][][][][][][]NOTIFICATION OFMAJOR HOLDINGS (tobe sent to therelevantissuer and to theFCA in MicrosoftWord format ifpossible) [i] 1a. Identity of the IOG plcissuer or theunderlying issuer ofexisting sharesto which votingrights areattached [ii]:1b. Please indicateif the issuer isa non-UK issuer (please mark withan "X" ifappropriate)Non-UK issuer2. Reason for thenotification (pleasemark theappropriate box orboxes with an"X")An acquisition or

Ponsse’s cooperation negotiations have ended

Ponsse PlcOther information published based on stock exchange rules, 24 August 2022 at 4:30 EEST Ponsse’s cooperation negotiations have ended Ponsse Plc’s cooperation negotiations pursuant to the Act on Co-operation within Undertakings have been completed today. The negotiations concerned Ponsse Plc’s all personnel groups and all operations in Finland, apart from technology company Epec Oy, covering a total of 1017 people. According to the negotiation results, the company will discharge 23 employees. The personnel reductions are divided into different functions of the company. In

CO2 Capsol AS: New share capital registered

Oslo, August 24, 2022Reference is made to CO2 Capsol AS’ (“CO2 Capsol" or the "Company") stockexchange announcement published on 11 August 2022 regarding the Board ofDirector's resolution to increase the Company's share capital pursuant to theboard authorization granted by the Company's general meeting held on 22 April2022.The increase of capital has now been registered with the Norwegian Register ofBusiness Enterprises (Nw. Foretaksregisteret). The new share capital of theCompany is NOK 53,533,395, divided into 53,533,395 shares, each with a par valueof NOK 1. Each share

Kristian Pullola succeeds Mika Stirkkinen as Finnair Chief Financial Officer

Finnair Plc                                   Stock Exchange Release                 24 August 2022 at 3.00 p.m. EEST Finnair has appointed Kristian Pullola, M.Sc. (Economics), 49, as Chief Financial Officer and member of the Finnair Executive Board as of 1 October 2022. Pullola will start at Finnair as an executive advisor already as of 1 September 2022. Finnair’s current CFO Mika Stirkkinen will act as an executive advisor as of 1 October 2022 and leaves Finnair on 31 October 2022. Kristian Pullola has previously worked for a long period as Chief Financial Officer of Nokia, and

Pomegranate Investment AB (publ) Annual Report for period 1 May 2021 – 30 April 2022

NOT FOR DISTRIBUTION IN THE UNITED STATES OR TO ANY U.S. PERSONDear Share owners, The annual report and auditors report are available at the company’s office, Mäster Samuelsgatan 1, 1st floor, SE-111 44 Stockholm, Sweden and will be sent to shareholders that so request and inform the company of their postal address. The annual report is now also made available on the Company’s website www.pomegranateinvestment.com For additional information, please visit the Company’s website at www.pomegranateinvestment.com or contact: Investor Relations contact: Gustav Wetterling, CFOTel:

Zwipe AS – notification of trade by related party of primary insider

OSLO, NORWAY – 24 August 2022 – KAD Group AS, a company 100% owned by the CFO of Zwipe AS, Danielle Glenn, has today acquired 12,000 shares in Zwipe AS. After this transaction, KAD Group AS holds 12,000 shares in Zwipe AS. The shares were acquired on Euronext Growth Oslo at a price of 8.30. Attached is a copy of the form submitted to the Norwegian FSA, Finanstilsynet, reporting the transaction as listed above. ### This information is subject to the disclosure requirements in Regulation EU 596/2014 article 19 number 3 and the Norwegian Securities Trading Act section 5-12, and is

Raisio's Financial Reporting and Annual General Meeting in 2023

Raisio plc, Stock Exchange Release, 24 August 2022 Raisio plc will publish its Financial Statements Bulletin for 2022 on Wednesday 8 February 2023 at approximately 8:30 a.m. Finnish time (EET). The Financial Statement, the Board of Directors' Report and the Corporate Responsibility information for 2022 will be published in week 12/2023. The publication dates of Raisio’s financial reports for 2023 are as follows:Interim Report for January-March on Wednesday, 3 May 2023Half-Year Financial Report for January-June on Wednesday, 9 August 2023Interim Report for January-September on

Securitas announces new financial targets and Stanley Security update

Following the acquisition of STANLEY Security, that was completed and consolidated into Securitas as of July 22, 2022, the Group has defined new financial targets of 8-10 percent technology & solutions annual average real sales growth, 8 percent Group operating margin by year-end 2025 and a net debt to EBITDA ratio below 3.0x. Securitas will present the strategy and roadmap for the new targets, as well as a trading update for STANLEY Security, at an investor update today at 2.00 p.m. CEST.Bringing together Securitas and STANLEY Security is an industry-defining event. We will have an

SKF announces changes to Group Management

Gothenburg, 24 August 2022: SKF announces the appointment of Annika Ölme as CTO and Senior Vice President, Technology Development. Annika joins SKF from SAAB Radar Solutions, where she is CTO and Head of Engineering. Annika has also been Managing Director of Arcam, a subsidiary of General Electric. Between 2002-2017, Annika held various positions within SKF. Annika has a Master of Science in Electrical Engineering from Chalmers University of Technology and a Master of Business Administration from Waikato University. Rickard Gustafson, President and CEO, says: “I’m happy to welcome

FluoGuide’s update on FG001’s clinical development

Copenhagen, Denmark, 24 August 2022 – FluoGuide A/S (“FluoGuide” or the “Company”) provides an update on the clinical development of FG001.FluoGuide announced in April FG001’s highly promising results in aggressive brain cancer (high grade glioma) following its phase I/IIa trial. FG001 was demonstrated to be well tolerated with only few patients reporting mild side effects (3 out of 40 patients). Furthermore, 100% of the biopsies from patients in the optimal dose (n=8, with 33 biopsies obtained) had their cancer illuminated. Based on these strong results, FluoGuide has decided to expand the

There are no items matching the current filter
There are no more items matching the current filter
Back to top